-
Mashup Score: 3Toward Personalized Treatment Approaches in Soft Tissue Sarcomas - 4 month(s) ago
Ciara Kelly, MBBCh, BAO, discusses personalized treatment approaches for patients with soft tissue sarcoma.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
The NCCN has updated their guidelines for soft tissue sarcoma to include the γ-secretase inhibitor nirogacestat as a systemic therapy option for patients with desmoid tumors, granting the agent a preferred, category 1 recommendation.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
.@NCCN Adds Nirogacestat to Guidelines for Patients With Soft Tissue Sarcoma #sarcoma https://t.co/CZnFKx1Lod
-
-
Mashup Score: 17Atezolizumab Shrinks Alveolar Soft Part Sarcomas - 4 month(s) ago
Treatment with atezolizumab (Tecentriq) shrank tumors in nearly 40% of people with alveolar soft part sarcoma, according to new clinical trial results.
Source: www.cancer.govCategories: General Medicine News, Onc News and JournalsTweet-
Treatment with atezolizumab (Tecentriq) shrank tumors in about 40% of people with alveolar soft part #sarcoma, including one complete response, new clinical trial findings show. Some people were later able to stop treatment without the cancer returning. https://t.co/ePXQGSc1Cb
-
-
Mashup Score: 1Nirogacestat Approval Offers Choice to Desmoid Tumor Population - 5 month(s) ago
The difference in adverse effect profiles between sorafenib and nirogacestat may make one treatment more appealing than the other for certain patients with desmoid tumors, says Brian Van Tine, MD, PhD.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet-
Brain Van Tine, MD, PhD, spoke about how the FDA approval of nirogacestat in progressing desmoid tumors may offer patients a choice when it comes to managing their disease. #sarcoma | @bvantine1 @WUSTL https://t.co/DmJHdY7JJM https://t.co/SnVD2FZyZ1
-
-
Mashup Score: 1A Cancer Diagnosis at 19 Taught Me That It Takes Constant Vigilance to Stay Mentally Healthy - The ASCO Post - 5 month(s) ago
A lot of my experience with cancer is hazy to me. I was taking narcotics for pain around the clock when I was diagnosed with Ewing’s sarcoma in 2013, so there are some missing memories during those early days. I was 19 and a freshman in college when my symptoms started. I have always been active in sports and was on the field a lot playing Ultimate Frisbee when I pulled a groin muscle that never got better. All t he pain was centered in my left hip and leg, and it would come in waves so severe it kept me
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet-
A Cancer Diagnosis at 19 Taught Me That It Takes Constant Patient's Corner: Vigilance to Stay Mentally Healthy, by Alec Kupelian https://t.co/EtZdMKOjia #sarcoma @alec_kupelian
-
-
Mashup Score: 0Examining Molecular Targets in Sarcoma - 5 month(s) ago
Mark Agulnik, MD, discusses advances in determining the molecular drivers of the tumor in the sarcoma space.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
WATCH: Mark Agulnik, MD, discusses advances in determining the molecular drivers of the tumor in the #sarcoma space. @AgulnikMd @cityofhope https://t.co/ZtkKxZFuam
-
-
Mashup Score: 0
TBI-1301 demonstrated superior efficacy compared with standard-of-care treatment in patients with synovial sarcoma. Further research is warranted.
Source: www.targetedonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Immunotherapy + TBI-1301 to target NY-ESO-1+ tumor cells demonstrated promising results for treating advanced or recurrent synovial #sarcoma. https://t.co/XFLs378RMg
-
-
Mashup Score: 0ESMO Sarcoma and Rare Cancers Congress 2024: Registration - 7 month(s) ago
Registration is now open
Source: www.esmo.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Registration now open for ESMO Sarcoma and Rare Cancers 2024. The scientific & educational programme will feature insights into diagnosis, prognostication, managemt & ongoing research. https://t.co/6V8Ggdarw8 #ESMOSarcomaAndRareCancers24 #scmsm #rarecancer @jeanyvesblay #sarcoma https://t.co/bEk00NtuaS
-
-
Mashup Score: 0
In August 2014, just a few weeks after my 15th birthday, my body began sending me a lot of worrisome signals that life as I knew it would soon be over. The year before, I had developed a hematoma in my right femur, which was resolved with surgery. But now the pain I was experiencing in that leg was even more i ntense than it had been the previous year, making it difficult to walk, and I was also having unexplained chronic fevers. Thinking the hematoma had recurred, my parents took me to see the surgeon
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
A Diagnosis of Ewing Sarcoma Altered the Trajectory of My Life, by Mafalda Von Alvensleben https://t.co/W82DzbIXY4 #sarcoma @VonMafalda
-
-
Mashup Score: 2Catalyzing Change Young Moroccan Oncologists Spearhead the Fight Against Sarcoma - The ASCO Post - 7 month(s) ago
The management of sarcoma presents several challenges because of its rarity and diverse subtypes, making accurate diagnosis and specialized treatment crucial. A multidisciplinary approach involving various experts from different cancer specialties is the optimal strategy to improve survival and reduce recurrence rates. Limited awareness and expertise in s arcoma among health-care professionals may lead to delayed or suboptimal management, emphasizing the importance of specialized sarcoma centers, particula
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Catalyzing Change: Young Moroccan Oncologists Spearhead the Fight Against Sarcoma https://t.co/8G18iQ7tKs #sarcoma #oncology #Morocco
-
Ciara Kelly, MBBCh BAO, explores recent advancements toward personalized treatment in soft tissue sarcoma. #sarcoma | @MSKCancerCenter https://t.co/wbe1aZsDqP